Analysis reveals US pharma giant Pfizer allocated more revenue to shareholders than R&D in 2024, as Trump's drug price rhetoric targets allies over corporate profits. Explore the real drivers of high US medicine costs.
The highest-earning partner at law firm Pinsent Masons received £1.27m last year, a significant drop from £1.7m, as firm profits softened. Discover the financial details and strategic outlook.
GSK strikes a voluntary agreement with the US government to lower prescription medicine costs by up to 66% and bolster American drug supply chains. Read the full details.
WH Smith's profits plummet to £16m as the FCA launches a formal investigation. The retailer is attempting to recover £7m in bonuses from former executives. Read the full story.
A top partner at elite City law firm Macfarlanes earned a record £5m last year, as profits soar and pay for senior lawyers reaches new heights. Discover the figures behind the UK's legal pay boom.
BP appoints Meg O'Neill as its first female chief executive to accelerate a strategic pivot back to oil and gas. Discover the investor pressure driving this historic change.
MPs warn UK's 'milestone' zero-tariff drug deal with the US is 'built on sand' with no legal text. Concerns grow as a separate £31bn tech deal is paused. Could the NHS pay more for nothing?
New UK-US medicines agreement aims to boost NHS access to innovative drugs, but critics warn of eroded sovereignty in wider trade pacts with Trump. Explore the debate.
New data reveals over 6,500 Australian doctors received payments from drug firms. Experts warn this influences prescriptions, raising serious healthcare ethics questions. Read the full investigation.
UK hotels face a profit squeeze as rising costs outpace increased demand and room rates. Experts warn of challenges from wage hikes and frozen tax thresholds. Read the full analysis.
Thames Water reports a £386m half-year profit, driven by higher bills, but warns of a potential rapid collapse into government control due to its £17bn debt crisis. Read the latest on the utility's precarious future.
A new UK-US deal doubling spending on US medicines raises NHS funding fears. Experts warn of a 'problematic precedent' that could impact Australia and global healthcare systems.
The UK has secured a major three-year deal for zero US import tariffs on pharmaceuticals, safeguarding £5bn in annual exports and boosting life sciences investment. Read the full analysis.
The UK and US have agreed a landmark deal maintaining zero tariffs on pharmaceuticals, while the NHS commits to a 25% net price increase for new medicines. Explore the details and implications.
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products, ensuring access to latest medical breakthroughs. Read the full details.
London broker Peel Hunt reports an 800% profit surge to £11.5m, driven by a revival in corporate dealmaking. Discover the key figures and strategic outlook for the UK investment bank.
US regulator FDA announces major overhaul of vaccine approval process following COVID-19 review. New protocols aim to strengthen public trust in immunisation programmes.
Mitchells & Butlers reports strong £2.7bn revenue and 20% profit growth while facing £130m cost pressures from wage hikes and inflation. Discover how pub giants navigate economic challenges.
Labour's North Sea oil strategy faces criticism as energy department's pragmatic licensing clashes with Treasury's windfall tax, creating uncertainty for jobs and investment.
Pets at Home reports 33.5% profit drop to £36.2m as retail business falters. Interim CEO announces urgent action needed to return to retailing roots. Read the full analysis.
B&Q owner Kingfisher boosts profit outlook despite softening UK retail market. Discover how strong management drives success in challenging economic conditions.
easyJet announces new Stansted to Paris flights starting March 2026, alongside better-than-expected annual profits driven by package holiday demand. Book your seats now!
EasyJet reports a 9% rise in annual profits to £665m, driven by strong demand for package holidays. Discover how popular destinations and strategic expansion fuel growth.
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Read the latest on the pharmaceutical giant's market struggles.
UK housebuilder Crest Nicholson announces 100 job cuts and profit warning following challenging market conditions and government property tax changes. Full analysis inside.
Chancellor Rachel Reeves considers a bank surcharge hike despite competitiveness fears. The Budget U-turn follows record £50.3bn bank profits. Discover the implications.
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.
Deutsche Bank CEO Christian Sewing announces ambitious turnaround plan targeting €2.5bn profit and €2bn cost savings by 2025, declaring the bank is 'fully back' after years of restructuring.
Saudi Arabia's massive oil profits create climate action paradox as desert kingdom faces extreme heat threats while blocking global fossil fuel phaseout.
Private companies providing care services extracted £256m in profits across three English regions between 2021-2024, with over a third going to private equity and tax haven firms.